Genomic characterization and prognosis of pancreatic adenosquamous carcinoma
Pancreatology · 2026
DOI: 10.1016/j.pan.2025.12.018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pancreatology, 2026. Verfasst von Yingying Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Oncology Department, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing,…. Hauptthemen laut MEDLINE: Carcinoma, Adenosquamous, Pancreatic Neoplasms. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Peking Union Medical College Hospital, Peking Union Medical College.
Abstract (Originalsprache)
Pancreatic adenosquamous carcinoma (PASC) is a highly rare and aggressive disease with poor prognosis. The median overall survival is less than one year. Aiming to identify the genomic characterization of the PASC, we conducted a retrospective analysis of the clinical characteristics and genomic alterations in 14 patients with PASC who underwent surgery at Beijing Hospital and Peking Union Medical College Hospital from 2010 to 2021. Genomic alterations were identified using targeted panel sequencing. We developed a PASC-specific signature to aid in the prognostic stratification of these patients. Our study revealed several genetic alterations potentially contributing to the development and progression of PASC, including TP53 mutations, MYC amplification, and CDKN2A deletion. Pathway enrichment analysis indicated that STK11 mutations, high tumor mutational burden (TMB-H), APC deletion, TERT/RICTOR amplification, and chromosomal instability (CIN-H) were significantly associated with altered pathways. Additionally, we confirmed the prognostic value of our PASC-specific signature through validation in an independent cohort of pancreatic ductal adenocarcinoma patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Oncology Department, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
- Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
- Department of Pathology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
- Department of Medicine, Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu, China.
- Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. Electronic address: wangxiang@pumch.cn.
- Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Förderung
- Peking Union Medical College Hospital
- Peking Union Medical College
Zitieren
APA
Huang, Y., Chang, X., Du, J., Zhang, S., Wang, S., Wang, X., & Bai, C. (2026). Genomic characterization and prognosis of pancreatic adenosquamous carcinoma. Pancreatology. https://doi.org/10.1016/j.pan.2025.12.018
Vancouver
Huang Y, Chang X, Du J, Zhang S, Wang S, Wang X, et al. Genomic characterization and prognosis of pancreatic adenosquamous carcinoma. Pancreatology. 2026. doi:10.1016/j.pan.2025.12.018
BibTeX
@article{Huang2026,
author = {Huang, Yingying and Chang, Xiaoyan and Du, Jun and Zhang, Shuai and Wang, Sha and Wang, Xiang and Bai, Chunmei},
title = {Genomic characterization and prognosis of pancreatic adenosquamous carcinoma},
journal = {Pancreatology},
year = {2026},
doi = {10.1016/j.pan.2025.12.018}
}
EUVIMED